Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Childhood Cancers
Both
Childhood Cancers
Trial Information
Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
Inclusion Criteria:
- biological or foster parent of children under 18 years of age who are scheduled for
HSCT within the next month
- participant is the primary caregiver
- participant must have phone service
- caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens
Hospital Los Angeles and Columbia University only)
Exclusion Criteria:
- pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Beck Depression Inventory
Outcome Time Frame:
Baseline, 1 month post-baseline, 6 mos post-baseline, 12 mos post-baseline
Safety Issue:
No
Principal Investigator
Sharon L Manne, Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Medicine and Dentistry New Jersey
Authority:
United States: Institutional Review Board
Study ID:
IRB#07-848; 15032-01
NCT ID:
NCT00939380
Start Date:
August 2008
Completion Date:
August 2013
Related Keywords:
- Childhood Cancers
- hematopoietic stem cell transplant
- bone marrow transplant
- children
- parents
- counseling
- depression
Name | Location |
|---|---|
| Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
| Childrens Hospital Los Angeles | Los Angeles, California 90027 |
| Columbia University | New York, New York 10032-3784 |
| Emory University/Childrens Healthcare of Atlanta | Atlanta, Georgia 30322 |
| Umdnj Cinj | New Brunswick, New Jersey 080903 |
